Cargando…
CD37 high expression as a potential biomarker and association with poor outcome in acute myeloid leukemia
Background: CD37, a member of the transmembrane 4 superfamilies (TM4SF), has been proved to be abnormally expressed in a range of malignancies. Herein, we investigate the effects of CD37 expression and analyze its clinical outcome in acute myeloid leukemia (AML) patients. Methods: The RNA-seq and cl...
Autores principales: | Zhang, Qi, Han, Qi, Zi, Jie, Song, Chunhua, Ge, Zheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253400/ https://www.ncbi.nlm.nih.gov/pubmed/32400873 http://dx.doi.org/10.1042/BSR20200008 |
Ejemplares similares
-
Elevated TNFRSF4 gene expression is a predictor of poor prognosis in non-M3 acute myeloid leukemia
por: Gu, Siyu, et al.
Publicado: (2020) -
FBXW4 Is Highly Expressed and Associated With Poor Survival in Acute Myeloid Leukemia
por: Han, Qi, et al.
Publicado: (2020) -
Integrated analysis reveals distinct molecular, clinical, and immunological features of B7‐H3 in acute myeloid leukemia
por: Zhang, Ling‐yi, et al.
Publicado: (2021) -
Clinical and prognostic relevance of CXCL12 expression in acute myeloid leukemia
por: Wang, Shi-sen, et al.
Publicado: (2021) -
Immune‐relatedlncRNAs can predict the prognosis of acute myeloid leukemia
por: Li, Ran, et al.
Publicado: (2021)